Press Releases

LogiPharma leads the way as Tower takes cold chain containers on the road

About Tower www.towercoldchain.com Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable and reusable containers are the essential link in the stability of the cold chain. Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers. We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world. We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection. For Tower sales enquiries please contact: Nick Gilmore, Global Head of Sales & Marketing Email: Nick.Gilmore@towercoldchain.com For Tower media enquiries please contact: Simon Kinnear or Rhiannon Hopper, Nielsen McAllister Tel: +44 (0)1332 293939 Email: tower@nmpr.co.uk

INCOG BioPharma Services builds state-of-the-art facility with promise to deliver a better customer experience

ArisGlobal Closes 2021 with Tremendous Growth Across Customer Base, Talent, and Revenue, Further Solidifying Its Leadership in Life Sciences R&D Software

Life sciences technology pioneer delivers record bookings and double-digit increase in revenue; Gears up for the future with investments in LifeSphere SaaS platform

BOC Sciences Provides PseudoUridines for Vaccine R&D

Alfa Chemistry Releases Functional PEGs for Biological and Therapeutic Research

Protection Reagents Optimized to Facilitate Organic Synthesis at Alfa Chemistry

Rho Promotes Mark Ubert to CFO

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has promoted Mark Ubert, MBA, to the position of Chief Financial Officer (CFO). As CFO, Mark will provide financial and strategic leadership to the growing organization, exemplified in the role he played in Rho’s acquisition of European CRO Dokumeds. Mark brings more than 30 years of experience to the role of Chief Financial Officer. He joined Rho in March of 2020 as VP of Finance.

Dolomite Bio announce launch of cost-effective Bioinformatics service with brand new RNAdia kit for single cell research

Dolomite Bio has announced the launch of a Bioinformatics Service which can be purchased alongside the recently launched RNAdia kit for single-cell research.

Flourish Research Adds Great Lakes Clinical Trials and Clinical Site Partners to the Network, Tripling Revenue and Expanding Clinical Expertise in Six Months

Great Lakes Clinical Trials and Clinical Site Partners join Excel Medical Clinical Trials and platform site Clinical Trials of Texas at Flourish Research, expanding capabilities to 60 indications.

Improved Image Quality and Resolution for all ZEISS Laser Scanning Microscopes

ZEISS LSM Plus and ZEISS Airyscan Joint Deconvolution introduced

Creative Bioarray Provides Reliable and Consistent FBS Products to Faciliatate The Research of Cell Culture

Creative Bioarray Launches A Wide Range of FISH Services to Support Detecting RNA and DNA Sequences

Histobiolab Has Developed Professional Tissue Microarray to Meet Precise Research Needs

Creative Biogene Provides Reliable and High Quality Pseudovirus Services to Support The Studies of SARS-CoV-2

Qvirus Platform Designed Customized AAV Testing Services to Accelerate The Development of Viral Vaccine and Gene Therapy

Microbiosci Provides Comprehensive Service for Pichia Pastoris Fermentation to Process Development of Microbiological Research

CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects

Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research

Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.

Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.